Efficacy and safety of secukinumab in moderate to severe plaque psoriasis

被引:0
|
作者
Aparicio Rubio, Celia [1 ]
Monteagudo Santolaya, Emilio [1 ]
Cornejo Uixeda, Silvia [1 ]
Prieto Castello, Manuel [1 ]
Antonino de la Camara, Gonzalo [1 ]
Quintana Vergara, Belen [1 ]
Sanchez Alcaraz, Agustin [1 ]
机构
[1] Hosp Univ Ribera, Alzira, Spain
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PT019
引用
收藏
页码:299 / 299
页数:1
相关论文
共 50 条
  • [1] Effectiveness and safety of secukinumab in patients with moderate to severe plaque psoriasis
    Moron, R.
    Alvarez, R.
    Nieto, P.
    Garcia, C.
    Belda, S.
    Cabeza, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 378 - 378
  • [2] Secukinumab: A Review in Moderate to Severe Plaque Psoriasis
    Garnock-Jones, Karly P.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2015, 16 (04) : 323 - 330
  • [3] Secukinumab: A Review in Moderate to Severe Plaque Psoriasis
    Karly P. Garnock-Jones
    American Journal of Clinical Dermatology, 2015, 16 : 323 - 330
  • [4] Efficacy and safety of etanercept in moderate to severe plaque psoriasis
    Tunca, M.
    Koc, E.
    Akar, A.
    Kurumlu, Z.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 53 - 53
  • [5] Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response and Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)
    Elewski, B.
    Lebwohl, M.
    Papp, K.
    Nakagawa, H.
    Sigurgeirsson, B.
    Tsai, T. -F.
    Tyring, S.
    Hampele, I.
    Karpov, A.
    Helou, S.
    Papavassilis, C.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2014, 55 : 43 - 43
  • [6] Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response And Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)
    Elewski, B.
    Lebwohl, M.
    Papp, K.
    Nakagawa, H.
    Sigurgeirsson, B.
    Tsai, T.
    Tyring, S.
    Hampele, I.
    Karpov, A.
    Helou, S.
    Papavassilis, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 15 - 15
  • [7] Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis
    Blair, Hannah A.
    PEDIATRIC DRUGS, 2021, 23 (06) : 601 - 608
  • [8] Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis
    Hannah A. Blair
    Pediatric Drugs, 2021, 23 : 601 - 608
  • [9] Efficacy and safety of secukinumab in the treatment of moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials
    Xiong, Hui-Zi
    Gu, Jun-Ying
    He, Zhi-Gang
    Chen, Wen-Juan
    Zhang, Xiao
    Wang, Jia-Yi
    Shi, Yu-Ling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 3156 - 3172
  • [10] Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies
    Koerber, Andreas
    Papavassilis, Charis
    Bhosekar, Vaishali
    Reinhardt, Maximilian
    DRUGS & AGING, 2018, 35 (02) : 135 - 144